Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rγ null mice is enhanced by transgenic expression of membrane-bound human SCF.

Brehm MA, Racki WJ, Leif J, Burzenski L, Hosur V, Wetmore A, Gott B, Herlihy M, Ignotz R, Dunn R, Shultz LD, Greiner DL.

Blood. 2012 Mar 22;119(12):2778-88. doi: 10.1182/blood-2011-05-353243. Epub 2012 Jan 12.

2.

Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation.

Takagi S, Saito Y, Hijikata A, Tanaka S, Watanabe T, Hasegawa T, Mochizuki S, Kunisawa J, Kiyono H, Koseki H, Ohara O, Saito T, Taniguchi S, Shultz LD, Ishikawa F.

Blood. 2012 Mar 22;119(12):2768-77. doi: 10.1182/blood-2011-05-353201. Epub 2012 Jan 25.

3.

Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.

McIntosh BE, Brown ME, Duffin BM, Maufort JP, Vereide DT, Slukvin II, Thomson JA.

Stem Cell Reports. 2015 Feb 10;4(2):171-80. doi: 10.1016/j.stemcr.2014.12.005. Epub 2015 Jan 15.

4.

NOD Scid Gamma Mice Are Permissive to Allogeneic HSC Transplantation without Prior Conditioning.

Verbiest T, Finnon R, Brown N, Finnon P, Bouffler S, Badie C.

Int J Mol Sci. 2016 Nov 7;17(11). pii: E1850.

5.

Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice.

Chen BP, Galy A, Kyoizumi S, Namikawa R, Scarborough J, Webb S, Ford B, Cen DZ, Chen SC.

Blood. 1994 Oct 15;84(8):2497-505.

6.

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.

Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R.

J Immunol. 2005 May 15;174(10):6477-89.

7.

Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.

Brehm MA, Cuthbert A, Yang C, Miller DM, DiIorio P, Laning J, Burzenski L, Gott B, Foreman O, Kavirayani A, Herlihy M, Rossini AA, Shultz LD, Greiner DL.

Clin Immunol. 2010 Apr;135(1):84-98. doi: 10.1016/j.clim.2009.12.008. Epub 2010 Jan 21.

8.

Comparison of human cord blood engraftment between immunocompromised mouse strains.

McDermott SP, Eppert K, Lechman ER, Doedens M, Dick JE.

Blood. 2010 Jul 15;116(2):193-200. doi: 10.1182/blood-2010-02-271841. Epub 2010 Apr 19.

9.

Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.

Heinz N, Ehrnström B, Schambach A, Schwarzer A, Modlich U, Schiedlmeier B.

Stem Cells Transl Med. 2015 Sep;4(9):1064-72. doi: 10.5966/sctm.2014-0284. Epub 2015 Jul 9.

10.

Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.

Pearson T, Shultz LD, Miller D, King M, Laning J, Fodor W, Cuthbert A, Burzenski L, Gott B, Lyons B, Foreman O, Rossini AA, Greiner DL.

Clin Exp Immunol. 2008 Nov;154(2):270-84. doi: 10.1111/j.1365-2249.2008.03753.x. Epub 2008 Sep 8.

11.

Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice.

Drake AC, Khoury M, Leskov I, Iliopoulou BP, Fragoso M, Lodish H, Chen J.

PLoS One. 2011 Apr 29;6(4):e18382. doi: 10.1371/journal.pone.0018382.

12.

Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain.

Coughlan AM, Harmon C, Whelan S, O'Brien EC, O'Reilly VP, Crotty P, Kelly P, Ryan M, Hickey FB, O'Farrelly C, Little MA.

Stem Cells Dev. 2016 Apr 1;25(7):530-41. doi: 10.1089/scd.2015.0289.

PMID:
26879149
13.

Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.

Covassin L, Jangalwe S, Jouvet N, Laning J, Burzenski L, Shultz LD, Brehm MA.

Clin Exp Immunol. 2013 Dec;174(3):372-88. doi: 10.1111/cei.12180.

14.

Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.

Wulf-Goldenberg A, Keil M, Fichtner I, Eckert K.

Tissue Cell. 2012 Apr;44(2):80-6. doi: 10.1016/j.tice.2011.11.004. Epub 2011 Dec 23.

PMID:
22197619
15.

Antioxidant N-acetyl-L-cysteine increases engraftment of human hematopoietic stem cells in immune-deficient mice.

Hu L, Cheng H, Gao Y, Shi M, Liu Y, Hu Z, Xu J, Qiu L, Yuan W, Leung AY, Yang YG, Cheng T.

Blood. 2014 Nov 13;124(20):e45-8. doi: 10.1182/blood-2014-03-559369. Epub 2014 Oct 6.

16.

Comparison of Human Hematopoietic Reconstitution in Different Strains of Immunodeficient Mice.

Beyer AI, Muench MO.

Stem Cells Dev. 2017 Jan 15;26(2):102-112. doi: 10.1089/scd.2016.0083. Epub 2016 Oct 27.

PMID:
27758159
17.

Evaluation of the efficiency of human immune system reconstitution in NSG mice and NSG mice containing a human HLA.A2 transgene using hematopoietic stem cells purified from different sources.

Patton J, Vuyyuru R, Siglin A, Root M, Manser T.

J Immunol Methods. 2015 Jul;422:13-21. doi: 10.1016/j.jim.2015.02.007. Epub 2015 Mar 14.

18.

An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses.

Singh M, Singh P, Gaudray G, Musumeci L, Thielen C, Vaira D, Vandergeeten C, Delacroix L, Van Gulck E, Vanham G, de Leval L, Rahmouni S, Moutschen M.

PLoS One. 2012;7(6):e38491. doi: 10.1371/journal.pone.0038491. Epub 2012 Jun 4.

19.

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M.

Blood. 2005 Sep 1;106(5):1565-73. Epub 2005 May 26.

20.

Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells.

Hasgur S, Aryee KE, Shultz LD, Greiner DL, Brehm MA.

Methods Mol Biol. 2016;1438:67-78. doi: 10.1007/978-1-4939-3661-8_4.

Supplemental Content

Support Center